About Computational Biology & AI Design
The Computational Biology & AI Design category is part of the Synthetic Biology market map, tracking 13 companies building in this segment. DNA synthesis, biomanufacturing, lab automation, and computational biology programming biology like software. Curated by Hartmann Capital's venture research team.
Companies in Computational Biology & AI Design
- Generate Biomedicines — Series C, $700M
- Absci — Public, $425M
- Cradle — Series B, $103M
- EvolutionaryScale — Seed, $142M
- Profluent — Series B, $150M
- BigHat Biosciences — Series B, $100M
- Xaira Therapeutics — Series A, $1B
- Evozyne — Series A, $81M
- Asimov — Series B, $200M
- Basecamp Research — Series A, $30M
- Bioptimus — Seed, $35M
- Noetik — Series A, $40M
- Deepcell — Series B, $63M
Frequently Asked Questions
- What companies are in the Computational Biology & AI Design category?
- The Computational Biology & AI Design category includes 13 companies: Generate Biomedicines, Absci, Cradle, EvolutionaryScale, Profluent, BigHat Biosciences, Xaira Therapeutics, Evozyne, Asimov, Basecamp Research, Bioptimus, Noetik, Deepcell. This is part of the Synthetic Biology market map maintained by Hartmann Capital.
- How many Computational Biology & AI Design startups are tracked?
- Hartmann Capital tracks 13 companies in the Computational Biology & AI Design segment of the Synthetic Biology market map.
- What are the best funded Computational Biology & AI Design companies?
- Top funded companies in Computational Biology & AI Design include Xaira Therapeutics ($1000M), Generate Biomedicines ($700M), Absci ($425M), Asimov ($200M), Profluent ($150M). Browse the full list in the Synthetic Biology market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.